Campbell & Co Investment Adviser’s Insmed INSM Stock Holding History

Campbell & Co Investment Adviser’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.68M	Buy	+43,856	New	+$5.31M	0.25%	91
2026 Q1	–	Sell	-21,910	Closed	-$3.81M	–	1226
2025 Q4	$3.81M	Buy	21,910 +2,850	+15%	+$520K	0.18%	154
2025 Q3	$2.74M	Buy	+19,060	New	+$2.33M	0.21%	114
2024 Q4	–	Sell	-38,649	Closed	-$2.82M	–	1195
2024 Q3	$2.82M	Buy	+38,649	New	+$2.85M	0.21%	107
2024 Q1	–	Sell	-54,928	Closed	-$1.7M	–	1244
2023 Q4	$1.7M	Buy	+54,928	New	+$1.42M	0.15%	184
2022 Q3	–	Sell	-11,275	Closed	-$222K	–	803
2022 Q2	$222K	Buy	+11,275	New	+$236K	0.06%	570
2017 Q4	–	Sell	-8,194	Closed	-$256K	–	450
2017 Q3	$256K	Buy	+8,194	New	+$156K	0.21%	203

Other funds holding INSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Campbell & Co Investment Adviser's INSM Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Insmed (INSM) in Q2 2026: 43,856 shares worth $4.68M. The stake represents 0.25% of the portfolio and ranks #91 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in INSM as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in INSM in Q3 2017 and has held it in 7 quarters since. 281 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Campbell & Co Investment Adviser held 43,856 shares of Insmed worth $4.68M as of Q2 2026.
Insmed was a new Campbell & Co Investment Adviser position in Q2 2026.
Insmed made up 0.25% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #91 holding.
Campbell & Co Investment Adviser first reported a position in Insmed in Q3 2017 and has held it in 7 quarters since.
281 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.